Target Fund Managers (TFML), the investment manager of FTSE 250 purpose built care home investor Target Healthcare REIT (THRL), announces the appointment of James MacKenzie to the newly created role of Head of Investor Relations.

James will lead TFML’s investor relations function, with a particular focus on growing and broadening its capital partner base, including on behalf of THRL. James will also work closely with the TFML Executive team to grow the business’s footprint, across both existing and new strategies, supporting the future shape and direction of the business.

James brings over 20 years of corporate advisory, relationship management and corporate governance experience. Most recently he was General Counsel and Company Secretary at Aegon UK and has also built experience from working at other blue chip financial services companies including Alliance Trust Equity Partners and F&C Asset Management.

At Aegon UK, James provided strategic legal counsel to the Board and played a key role in driving and supporting major business change programmes, including the acquisition of BlackRock’s Defined Contribution pensions administration business and the acquisition of Cofunds. He was also Executive lead for Sustainability for Aegon UK.

Target Fund Managers’ current assets under management exceeds £1 billion across its listed and unlisted mandates. This is exclusively in its core strategy of modern, fit for purpose care homes, with over 100 properties across the UK let to over 40 tenants.

Kenneth MacKenzie, Chief Executive of Target Fund Managers, commented: “James is highly qualified and brings a wealth of UK corporate advisory experience. His fresh perspectives and deep understanding of the UK institutional investor landscape – in particular the pension and insurance cohort and how the regulatory landscape is driving Defined Contribution market reform – will complement the existing Executive team’s diverse skill set, as we look to scale our portfolio of best in class healthcare real estate.”

James MacKenzie, Head of Investor Relations, at Target Fund Managers, added: “As markets stabilise, there is a sizeable opportunity to connect patient capital with a part of the market offering predictable, long-term income streams and capital appreciation, alongside a very powerful social impact. The TFML track record speaks for itself, and I am excited by the opportunity to play an integral role in the next stage of its growth.”